Kali Phos 6X

Manufacturer
Hyland's Inc.
Effective date
2025-04-30
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:33:30

Label at a glance#

ProductKali Phos 6X
Active ingredientPOTASSIUM PHOSPHATE, DIBASIC
Label structure8 sections

Indications and uses

■ Temporarily relieves: ■ stress ■ simple nervous tension ■ headaches

Dosage and administration

■ Use as directed. ■ Adults and children 6 years and over: Dissolve 1 tablet under tongue 3 times per day.

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

Stress

Simple Nervous Tension

Headaches

Drug Facts

SPL UNCLASSIFIED SECTION

OTC - ACTIVE INGREDIENT SECTION

Active ingredientsPurpose
Kali Phosphoricum 6X HPUSstress, simple nervous tension, headaches

"HPUS" is the Homeopathic Pharmacopoeia of the United States.

Uses

INDICATIONS & USAGE SECTION

■ Temporarily relieves:
■ stress ■ simple nervous tension ■ headaches

Warnings

WARNINGS SECTION

Stop use and ask a doctor if

OTC - STOP USE SECTION

■ symptoms persist for more than 72 hours or worsen.
■ new symptoms occur.
■ redness or swelling is present.

If pregnant or breastfeeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Directions

DOSAGE & ADMINISTRATION SECTION

■ Use as directed.
■ Adults and children 6 years and over: Dissolve 1 tablet under tongue 3 times per day.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Acacia Gum, Lactose

Questions?

OTC - QUESTIONS SECTION

Acacia Gum, Lactose

PACKAGING LABEL - 100 TABLETS BOTTLE CARTON

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Hyland's

CELL SALT

#6

KALI PHOS 6X

Stress*

Simple Nervous

Tension*

Headaches*

100

QUICK-DISSOLVING

SINGLE TABLET DOSES

HOMEOPATHIC

KAPH6X00T100CTNH1KAPH6X00T100CTNH1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54973-4092-1Kali Phos 6X1 in 1 CARTONTABLET, SOLUBLE14
54973-4092-1Kali Phos 6X100 in 1 BOTTLE, PLASTICTABLET, SOLUBLE1004

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54973-4092KALI PHOS 6X (POTASSIUM PHOSPHATE, DIBASIC) TABLET, SOLUBLE [HYLAND'S INC.]4Current NDC, Legacy NDC, 2 package rows20250502_dbfe86e8-c06f-2a84-e053-2a95a90a1f3d.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54973-409254973-4092-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Kali Phos 6XPOTASSIUM PHOSPHATE, DIBASICHyland's Inc.dbfe86e8-c06f-2a84-e053-2a95a90a1f3d2025-04-30WarningsExact identifier
ndc (package): 54973-4092-1
ndc (product): 54973-4092
ndc11 (package): 54973409201
spl id: 340ac69e-0018-804d-e063-6294a90ae8fe
spl set id: dbfe86e8-c06f-2a84-e053-2a95a90a1f3d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.